Interestingly, Yi et al. [50] have previously reported that valproate treatment has protective effects on a Drosophila model of MJD, decreasing apoptosis and alleviating climbing disability, without decreasing the presence of ataxin-3 protein aggregates. Here, ATXN3 is linked to Machado-Joseph disease.